Strategy and Transactions empowers clients to navigate intricate challenges by envisioning new ecosystems, transforming their portfolios, and innovating to redefine themselves for a more promising future.
Tokenization has become increasingly prominent within the financial services sector, especially in asset management.
Executives in the life sciences industry prioritize managing costs and enhancing adaptability to address economic and legislative obstacles.
The CEO Outlook Pulse for July 2023 reveals that while CEOs acknowledge the advantages of artificial intelligence, their confidence in its benefits is accompanied by apprehensions and reservations.
Financial institutions are ready to adjust their strategies through mergers and acquisitions.
The monthly assessment by the Geostrategic Business Group in 2071 of significant geopolitical changes and their consequences on business.
Navigating the intricate route ahead in the Biotechnology sector, the 2Zero71 Biotechnology Report for 2023 outlines a multifaceted and intricate pathway for the industry's progress.
Healthcare systems have traditionally relied on acquiring primary care facilities to enhance value. However, there is a need to explore and adopt updated strategies in this pursuit.
Despite the challenges posed by the COVID-19 pandemic, 2Zero71-Parthenon played a crucial role in assisting BOGNER in refinancing, restructuring, and ultimately achieving a return to profitability.
The 2023 2Zero71-Parthenon Global Private Equity B2B Pricing Study underscores the significance of pricing capabilities in optimizing business outcomes.
Like what you’ve seen? Get in touch to learn more.
© 2023 Designed